Literature DB >> 495629

Tuberculosis in patients undergoing maintenance hemodialysis.

A P Lundin, A J Adler, G M Berlyne, E A Friedman.   

Abstract

Tuberculosis was diagnosed in eight patients undergoing maintenance hemodialysis and occurred with an incidence 10 times that of the general population. Dialysis-associated tuberculosis is characterized by intermittent fever, anorexia, weight loss and hepatomegaly. Ascites was present in 50 per cent of the patients. A recently converted positive tuberculin skin test was observed in five of eight patients. Tuberculosis was extrapulmonary in seven of eight cases and consequently the diagnosis was frequently delayed. Over-all mortality was 37.5 per cent and correlated with the duration of symptoms prior to initiation of therapy. A trial of antituberculous therapy is warranted in patients undergoing dialysis in whom fever of unknown origin, anorexia, weight loss and/or hepatomegaly develop particularly in areas endemic for tuberculosis.

Entities:  

Mesh:

Year:  1979        PMID: 495629     DOI: 10.1016/0002-9343(79)90240-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

1.  High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.

Authors:  Susan Shin-Jung Lee; Kang-Ju Chou; Horng-Yunn Dou; Tsi-Shu Huang; Yen-Yun Ni; Hua-Chang Fang; Hung-Chin Tsai; Cheng-Len Sy; Jui-Kuang Chen; Kuang-Sheng Wu; Yung-Hsin Wang; Hsi-Hsun Lin; Yao-Shen Chen
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study.

Authors:  Shu-Yung Lin; Jia-Yih Feng; Chih-Yuan Lee; Yi-Chih Lin; Yu-Hsiang Chou; Kuan-Yin Lin; Yu-Feng Wei; Shu-Wen Lin; Chin-Hao Chang; Ping-Huai Wang; Chin-Chung Shu; Jann-Yuan Wang; Chong-Jen Yu
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

3.  Rare and unusual case of hepatic and disseminated tuberculosis in an immunocompetent patient.

Authors:  Celestine Eshiwe; Farah Shahi; Neil Gordon; Patrick Lillie
Journal:  BMJ Case Rep       Date:  2019-06-22

4.  Male-female differences in the risk of tuberculosis in dialysis patients.

Authors:  A I Christopoulos; A A Diamantopoulos; P A Dimopoulos; D S Goumenos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2008-10-24       Impact factor: 2.370

5.  High incidence of tuberculosis in renal patients.

Authors:  M E García-Leoni; C Martín-Scapa; P Rodeño; F Valderrábano; S Moreno; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

6.  Tuberculosis and renal transplantation--observations from an endemic area of tuberculosis.

Authors:  K K Malhotra; S C Dash; I K Dhawan; U N Bhuyan; A Gupta
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

7.  Breast mycobacterial infection in a haemodialysis patient.

Authors:  D Modai; J Weissgarten; R Reiff; B Siegal; D Gabizon
Journal:  Postgrad Med J       Date:  1984-02       Impact factor: 2.401

8.  Tuberculosis in patients with systemic lupus erythematosus.

Authors:  P H Feng; T H Tan
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

9.  Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial.

Authors:  Antonios I Christopoulos; Athanasios A Diamantopoulos; Panagiotis A Dimopoulos; Demetrios S Goumenos; George A Barbalias
Journal:  BMC Nephrol       Date:  2009-11-07       Impact factor: 2.388

10.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.